ADAMTS4 and ADAMTS5 are upregulated early in the DMM model of murine OA

ADAMTS4 and ADAMTS5 are upregulated early in the DMM model of murine OA

Bibliographic Details
Main Authors:	Burleigh, A, Saklatvala, J, Vincent, T
Format:	Journal article
Published:	2009

Similar Items

Proteolytic activities of human ADAMTS-5: comparative studies with ADAMTS-4.
by: Gendron, C, et al.
Published: (2007)

Fibroblast growth factor 2 is an intrinsic chondroprotective agent that suppresses ADAMTS-5 and delays cartilage degradation in murine osteoarthritis.
by: Chia, S, et al.
Published: (2009)

Purification and activity determination of ADAMTS-4 and ADAMTS-5 and their domain deleted mutants
by: Fowkes, MM, et al.
Published: (2019)

Engineering and expression of ADAMTS-4 and ADAMTS-5, proteolytic enzymes involved in osteoarthritis progression
by: Lauer-Fields, J, et al.
Published: (2005)

The C-terminal domains of ADAMTS-4 and ADAMTS-5 promote association with N-TIMP-3.
by: Troeberg, L, et al.
Published: (2009)

Functional differences of the catalytic and non-catalytic domains in human ADAMTS-4 and ADAMTS-5 in aggrecanolytic activity.
by: Fushimi, K, et al.
Published: (2008)

Cleavage of Fibulin-2 by the aggrecanases ADAMTS-4 and ADAMTS-5 contributes to the tumorigenic potential of breast cancer cells
by: Fontanil, T, et al.
Published: (2017)

Reactive-site mutants of N-TIMP-3 that selectively inhibit ADAMTS-4 and ADAMTS-5: biological and structural implications.
by: Lim, N, et al.
Published: (2010)

MECHANICAL LOAD DRIVES INFLAMMATORY GENE EXPRESSION AND DISEASE IN MURINE OA
by: Burleigh, A, et al.
Published: (2010)

Investigation of the endocytic pathway of ADAMTS-4
by: Owen, K, et al.
Published: (2009)

Pathogenic protease expression in murine OA is critically dependent upon mechanical joint loading
by: Burleigh, A, et al.
Published: (2012)

Low density lipoprotein receptor-related protein 1 (LRP1)-mediated endocytic clearance of a disintegrin and metalloproteinase with thrombospondin motifs-4 (ADAMTS-4): functional differences of non-catalytic domains of ADAMTS-4 and ADAMTS-5 in LRP1 binding.
by: Yamamoto, K, et al.
Published: (2014)

Development of selective ADAMTS-5 peptide substrates to monitor proteinase activity
by: Fowkes, MM, et al.
Published: (2023)

Interleukin-1α induces ADAMTS-mediated aggrecanolysis in the bovine meniscus: evidence for a primary role of ADAMTS-4 in meniscus destruction
by: Lemke, Angelika K., et al.
Published: (2012)

Screening for selective ADAMTS-5 substrates to monitor proteinase activity
by: Fowkes, MM
Published: (2021)

Altered proteolytic activities of ADAMTS-4 expressed by C-terminal processing.
by: Kashiwagi, M, et al.
Published: (2004)

The role of biomechanical factors in OA development
by: Burleigh, A, et al.
Published: (2010)

Analysis of the functional role of ADAMTS enzymes in prostate cancer
by: Molokwu, C, et al.
Published: (2005)

MMPs are less efficient than ADAMTS5 in cleaving aggrecan core protein.
by: Durigova, M, et al.
Published: (2011)

Novel role of ADAMTS-5 protein in proteoglycan turnover and lipoprotein retention in atherosclerosis.
by: Didangelos, A, et al.
Published: (2012)

Wherefore DMM?
by: Freeman, M, et al.
Published: (2008)

ADAMTS and ADAM metalloproteinases in osteoarthritis - looking beyond the ‘usual suspects’
by: Yang, C, et al.
Published: (2017)

Involvement of ADAMTS5 and hyaluronidase in aggrecan degradation and release from OSM-stimulated cartilage.
by: Durigova, M, et al.
Published: (2011)

Characterization of an ADAMTS-5-mediated cleavage site in aggrecan in OSM-stimulated bovine cartilage.
by: Durigova, M, et al.
Published: (2008)

TIMP-3 inhibits the procollagen N-proteinase ADAMTS-2.
by: Wang, WM, et al.
Published: (2006)

LRP-1-mediated endocytosis regulates extracellular activity of ADAMTS-5 in articular cartilage.
by: Yamamoto, K, et al.
Published: (2013)

Accelerated disease in a surgical model of murine OA in mice lacking FGF-2
by: Chia, S, et al.
Published: (2007)

New non-hydroxamic ADAMTS-5 inhibitors based on the 1,2,4-triazole-3-thiol scaffold.
by: Maingot, L, et al.
Published: (2010)

Development of a monoclonal anti-ADAMTS-5 antibody that specifically blocks the interaction with LRP1
by: Santamaria, S, et al.
Published: (2017)

Increased Von Willebrand factor, decreased ADAMTS13 and thrombocytopenia in melioidosis
by: Birnie, E, et al.
Published: (2017)

Androgen regulates ADAMTS15 gene expression in prostate cancer cells.
by: Molokwu, C, et al.
Published: (2010)

Regulation of ADAMTS expression in prostate cancer and stromal cells by androgen and TNF
by: Molokwu, C, et al.
Published: (2007)

Evaluating the role of ADAMTS proteoglycanases and TIMP-3 in prostate cancer progression
by: Adeniji, O, et al.
Published: (2007)

Cell surface nucleolin is a novel ADAMTS5 receptor mediating endothelial cell apoptosis
by: Kirman, Dogan Can, et al.
Published: (2022)

Calcium pentosan polysulfate increases affinity between aggrecanases (ADAMTS-4 and-5) and TIMP-3 by a conformational change
by: Troeberg, L, et al.
Published: (2010)

PARTIAL JOINT IMMOBILISATION PROTECTS AGAINST OA AND REVEALS DISTINCT BIOMECHANICAL THRESHOLDS IN THE JOINT
by: Burleigh, A, et al.
Published: (2010)

Genetic variation at the ADAMTS7 locus is associated with reduced severity of coronary artery disease
by: Chan, K, et al.
Published: (2017)

The expression and regulation of ADAMTS-1, -4, -5, -9, and -15, and TIMP-3 by TGFbeta1 in prostate cells: relevance to the accumulation of versican.
by: Cross, N, et al.
Published: (2005)

Severe malaria is associated with a deficiency of von Willebrand factor cleaving protease, ADAMTS13.
by: Löwenberg, E, et al.
Published: (2010)

ADAMTS13 is a Risk Factor for MI, Stroke and Vascular Death in the Oxford Vascular Study
by: Eglinton, J, et al.
Published: (2008)